Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics

SGMO POWR Grades

• SGMO scores best on the Value dimension, with a Value rank ahead of 71.09% of US stocks.
• SGMO's strongest trending metric is Growth; it's been moving down over the last 170 days.
• SGMO ranks lowest in Quality; there it ranks in the 3rd percentile.

SGMO Stock Summary

• Of note is the ratio of SANGAMO THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 4.66% of US stocks have a lower such ratio.
• As for revenue growth, note that SGMO's revenue has grown 79.75% over the past 12 months; that beats the revenue growth of 94.02% of US companies in our set.
• In terms of volatility of its share price, SGMO is more volatile than 93.27% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to SANGAMO THERAPEUTICS INC, a group of peers worth examining would be PTCT, HYMC, TSHA, IDR, and CRUS.
• SGMO's SEC filings can be seen here. And to visit SANGAMO THERAPEUTICS INC's official web site, go to www.sangamo.com.

SGMO Valuation Summary

• SGMO's price/earnings ratio is -0.3; this is 101.23% lower than that of the median Healthcare stock.
• Over the past 243 months, SGMO's price/earnings ratio has gone up 12.6.

Below are key valuation metrics over time for SGMO.

SGMO Growth Metrics

The 3 year net cashflow from operations growth rate now stands at -2300.02%.
• Its 2 year net cashflow from operations growth rate is now at -89.28%.
• The 4 year price growth rate now stands at 108.28%.

Over the past 52 months, SGMO's revenue has gone up $40,607,000.

The table below shows SGMO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	111.299	-223.627	-192.278
2022-09-30	112.055	-219.292	-177.801
2022-06-30	114.158	-225.094	-172.334
2022-03-31	112.652	-223.676	-176.33
2021-12-31	110.701	-233.251	-178.286
2021-09-30	108.515	-184.832	-181.394

SGMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SGMO has a Quality Grade of C, ranking ahead of 46.27% of graded US stocks.
• SGMO's asset turnover comes in at 0.127 -- ranking 244th of 682 Pharmaceutical Products stocks.
• ALBO, LXRX, and ATNX are the stocks whose asset turnover ratios are most correlated with SGMO.

The table below shows SGMO's key quality metrics over time.